FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Gly topics
Door Assembly
Swimming Goggles
Transverse
Alkoxylate
Fluoropolymer
Air Cleaning
Rotor Shaft
Aspect Ratio
Disconnect
Synchronization
Remote Control
Ethylene Glycol
Surfactant
Combustion
Steviol Glycosides

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Gly patents



      
           
This page is updated frequently with new Gly-related patent applications. Subscribe to the Gly RSS feed to automatically get the update: related Gly RSS feeds. RSS updates for this page: Gly RSS RSS


Date/App# patent app List of recent Gly-related patents
05/21/15
20150143584
 Nucleic acid molecules encoding polypeptides involved in regulation of sugar and lipid metabolism and methods of use viii patent thumbnailnew patent Nucleic acid molecules encoding polypeptides involved in regulation of sugar and lipid metabolism and methods of use viii
This invention relates generally to nucleic acid sequences encoding proteins that are related to the presence of seed storage compounds in plants. More specifically, the present invention relates to arabidopsis thaliana, brassica napus, glycine max and oryza sativa nucleic acid sequences encoding sugar and lipid metabolism regulator proteins and the use of these sequences in transgenic plants.
Basf Plant Science Gmbh
05/21/15
20150141680
 Enzymatic removal of steryl glycosides patent thumbnailnew patent Enzymatic removal of steryl glycosides
The present invention provides compositions and methods related to the production and use of enzymes suitable for reducing the amount of steryl glycosides or saturated monoacyl glycerols in a lipid mixture.. .
Keclon S.a.
05/21/15
20150141665
 Methods for preparing polymeric reagents patent thumbnailnew patent Methods for preparing polymeric reagents
The present invention provides among other things methods for preparing polymeric reagents, wherein the method comprises (a) providing an aromatic moiety bearing a hydroxy group, a first amino group and a second amino group; (b) reacting a functional group reagent with the hydroxy group to result in a hydroxy group bearing a functional group capable of reacting with an amino group of an active agent and resulting in a hydolyzable carbamate; and (c) reacting a plurality of poly(alkylene glycol) water-soluble polymers bearing a reactive group with the first amino group and second amino group to result in (i) a first amino group bearing a water-soluble polymer through a spacer moiety, and (ii) a second amino group bearing a second water-soluble polymer through a spacer moiety.. .
Nektar Therapeutics
05/21/15
20150141632
 High-purity steviol glycosides patent thumbnailnew patent High-purity steviol glycosides
Methods of preparing highly purified steviol glycosides, particularly rebaudioside d, are described. The methods include purification from the extraction stage of the stevia rebaudiana bertoni plant, purification of steviol glycoside mixtures, rebaudioside d and rebaudioside a from a commercial stevia extract, and purification of rebaudioside d from remaining solutions obtained after isolation and purification of rebaudioside a and a high purity mixture of steviol glycosides.
Purecircle Usa Inc.
05/21/15
20150141617
 Production and purification of active eukaryotic formylglycinegenerating enzyme (fge) variants patent thumbnailnew patent Production and purification of active eukaryotic formylglycinegenerating enzyme (fge) variants
The invention features compositions and methods for generation and uses of formylglycine generating enzyme (fge) variants.. .
Georg-august-universität Göttingen Stifung Öffentl
05/21/15
20150141512
 Polymer-based dialysate patent thumbnailnew patent Polymer-based dialysate
Embodiments described herein provide a dialysate comprising a polyglycerol. The polyglycerol may be of a molecular weight between about 0.15 kda and about 60 kda.
The University Of British Columbia
05/21/15
20150141508
 N-methyl-n-acylglucamine-containing composition patent thumbnailnew patent N-methyl-n-acylglucamine-containing composition
The invention relates to a clear composition which contains at least one anionic surfactant, a betaine surfactant, an n-methyl-n-acylglucamine, a triglyceride oil, a solvent and optionally an additive. The invention also relates to a method for producing the composition.
Clariant Finance (bvi) Limited
05/21/15
20150141505
 Broncholytic drug on the basis of prostaglandin patent thumbnailnew patent Broncholytic drug on the basis of prostaglandin
The invention relates to the field of medicine, and specifically to pulmonology, and concerns a method for treating inflammatory and obstructive diseases of the airways, in particular bronchial asthma and obstructive bronchitis, with the aid of a drug on the basis of 1′,3′-dinitroglycerol ester 11(s),15(s)-dihydroxy-9-keto-5z,13e-prostadienoic acid (nitroproston) having a marked bronchodilatory effect. The present invention provides for an expansion of the range of broncholytic drugs by the use of a derivative of natural prostaglandin e2, which is characterized by greater biological activity and the absence of noticeable side effects..
Obschestvo S Ogranichennoy Otvetstvennost'yu "prostanit Development
05/21/15
20150141474
 Cyclic ether dgat1 inhibitorscyclic ether dgat1 inhibitors patent thumbnailnew patent Cyclic ether dgat1 inhibitorscyclic ether dgat1 inhibitors
The invention relates to compounds of formula (i): useful for treating disorders mediated by acyl coa-diacylglycerol acyl transferase 1 (dgat1), e.g. Metabolic disorders.
Novartis Ag
05/21/15
20150141468
 Compositions and methods for the treatment of metabolic disorders patent thumbnailnew patent Compositions and methods for the treatment of metabolic disorders
The invention relates to the compounds of formula i or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula i, and methods for treating or preventing metabolic disorders may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection.
Mahesh Kandula
05/21/15
20150141457
new patent

Elvitegravir solid dispersion


The present invention provides a novel amorphous solid dispersion of elvitegravir in combination with a pharmaceutically acceptable carrier, process for its preparation and pharmaceutical compositions comprising it. In a preferred embodiment the process for the preparation of amorphous solid dispersion of elvitegravir in combination with a pharmaceutically acceptable carrier comprises: preparing a solution comprising a mixture of elvitegravir and one or more pharmaceutically acceptable carriers selected from copovidone, ethyl cellulose, hydroxypropyl methylcellulose, polyethylene glycol, span 20 or soluplus in a solvent; and removing the solvent from the solution obtained; adding hydrocarbon solvent to the residual solid; and isolating amorphous solid dispersion of elvitegravir in combination with a pharmaceutically acceptable carrier..
Hetero Research Foundation
05/21/15
20150141354
new patent

Glycoside derivatives and uses thereof


Wherein the variables are defined as herein above, which are useful for treating diseases and conditions mediated by the sodium d-glucose co-transporter (sglt), e.g. Diabetes.
05/21/15
20150141322
new patent

Therapeutic agent, treatment method and inspection diseases caused by activation or neutrophils


The present invention provides a therapeutic agent, a treatment method and an inspection method for diseases caused by activation of neutrophils. More specifically, the invention relates to a neutrophil activation regulator which comprising a histidine-rich glycoprotein (hrg) as an active ingredient, and provides a therapeutic agent for diseases caused by neutrophil activation comprising the neutrophil activation regulator, a treatment method for diseases caused by neutrophil activation, and further an inspection method for diseases caused by neutrophil activation.
National University Corporation Okayama University
05/21/15
20150141308
new patent

Energy efficient polyalkylene glycols and lubricant composition containing same


A polyalkylene glycol comprising: a random copolymer comprising units derived from eo and units derived from po initiated with polytetrahydrofuran; wherein the polyalkylene glycol has a pour point of less than or equal to −30° c. As measured using astm d97 and a traction value of less than 0.0165 at a contact pressure of 1.25 gpa, speed=2 m/s, srr of 100% and temperature of 80° c.
Dow Global Technologies Llc
05/21/15
20150141302
new patent

Composition containing an emulsified chelating agent and process to treat a subterreanean formation


The present invention relates to a composition containing a dispersed phase emulsified in a continuous phase, wherein at least 5 wt % on total weight of the dispersed phase of the composition is a chelating agent selected from the group of glutamic acid n,n-diacetic acid or a salt thereof (glda), aspartic acid n,n-diacetic acid or a salt thereof (asda), and methylglycine n,n-diacetic acid or a salt thereof (mgda), and a process for treating a subterranean formation comprising a step of introducing the above composition into the formation.. .
Akzo Nobel Chemicals International B.v.
05/21/15
20150141294
new patent

Reversible natural product glycosyltransferase-catalyzed reactions, compounds and related methods


The present invention relates to methods of use of glycosyltransferases and related novel compounds. The invention exploits the reversibility of glycosyltransferases to generate new sugars, unnatural biomolecules and numerous one-pot reactions for generation of new biomolecules having varied backbones such as enediynes, vancomycins, bleomycins, anthracyclines, macrolides, pluramycins, aureolic acids, indolocarbazoles, aminglycosides, glycopeptides, polyenes, coumarins, benzoisochromanequinones, calicheamicins, erythromycin, avermectins, ivermectins, angucyclines, cardiac glycosides, steroids or flavinoids.
Wisconsin Alumni Research Foundation
05/21/15
20150140659
new patent

Three-dimensional cell culture system and manufacturing method thereof


A three-dimensional cell culture system for an imaging system to observe a cell image includes at least two cell culture layers formed by a solution having a photo-polymerizable monomer, a bio-molecule, an acoustic scattering medium solution and a cell culture medium. After placing a cell into the two cell culture layers, the two cell culture layers are laminated to form a three-dimensional culture laminating layer for culturing the cell.
National Taiwan University
05/21/15
20150140640
new patent

Process for growing natural or engineered high lipid accumulating strain on crude glycerol and/or other sources of waste carbon for the production of oils, fuels, oleochemicals, and other valuable organic compounds


Disclosed herein are microorganisms capable of growing on crude glycerol and/or glycerol and/or methanol, or combinations thereof. In some embodiments the microorganisms are knallgas bacteria that produce or secrete at least 10% of lipid by weight.
Kiverdi, Inc.
05/21/15
20150140637
new patent

Process for the separation of a mixture of a protein and its reaction product with a polyalkylene glycol


The present invention relates to a process for the separation of a mixture of a protein and its reaction product with a polyalkylene glycol, comprising the steps: a) providing a mixture comprising the protein and the reaction product in a fluid, b) bringing the mixture of step a) into contact with a microporous cellulose acetate membrane with adsorption of the reaction product onto the cellulose acetate membrane, the protein not becoming adsorbed onto the cellulose acetate membrane, c) removal of the protein from the cellulose acetate membrane, and d) desorbing the reaction product from the cellulose acetate membrane, the reaction product being selected from the group comprising the protein which is mono- or polyfunctionalized by the polyalkylene glycol, or mixtures thereof.. .
Sartorius Stedim Biotech Gmbh
05/21/15
20150140576
new patent

Cancer specific glycans and use thereof


The present invention describes glycans, which are specifically expressed by certain cancer cells, tumours and other malignant tissues. The present invention describes methods to detect cancer specific glycans as well as methods for the production of reagents binding to said glycans.
Glykos Finland Oy
05/21/15
20150140516
new patent

Composition and using medicament for endodontic irrigation, stem cell preparation and tissue regeneration


A single intra-canal substance composition for tissue dissolution, disinfection, tissue degradation, tissue removal and disinfection is provided. The composition includes calcium hydroxide, sodium hydroxide, potassium thioglycolate or calcium thioglycolate, to form an effective single intra-canal substance capable of degrading a cell by disrupting its disulfide bonds.
05/21/15
20150140196
new patent

Crystallization accelerator


A crystallization accelerator includes a polymer compound that includes, as constituent components, a c18-28 hydroxy saturated fatty acid, which respectively has a hydroxyl group and a carboxyl group at both terminals and may have one carbonyl group in the chain thereof, a glycerin and optionally a fatty acid. The polymer compound is obtained by polymerizing the constituent components to a molecular weight of 3,000 to 100,000..
J-oil Mills, Inc.
05/21/15
20150140177
new patent

Shelf-stable, preservative-free liquid beverage enhancer products


A liquid beverage enhancer product including a shelf-stable highly concentrated liquid flavor and color solution including at least 10% non-water solvents with humectant properties including propylene glycol, glycerol, ethanol and other alcohols. The liquid beverage enhancer product in combination with beverages or non-beverage food products.
Amt Group, Llc Dba Imbibe
05/21/15
20150140163
new patent

Compositions and methods for coating dry pet food kibble


Compositions and methods are provided for evenly coating or glazing dry pet food kibbles for improved palatability without loss of crunchiness of the dry kibbles over an extended time period. The coating compositions comprise water and at least one of a gum or a modified starch.
Nestec Sa
05/21/15
20150140161
new patent

Methods of improving tolerance related to feeding in an infant, toddler, or child


Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component..
Abbott Laboratories
05/21/15
20150140142
new patent

Medicinal composition of extract of seed of emblica officinalis and preparing the same


A composition having an extract of seed of emblica officinalis. Methods of preparing extract of seed of emblica officinalis.
05/21/15
20150140139
new patent

Composition for improving or promoting hair growth containing, as active ingredients, photosensitizer irradiated with light and peptide, and method using same


The present invention relates to a composition for improving or promoting hair growth, which contains, as an active ingredient, a photosensitizer-peptide conjugate, and to a method for screening for the hair growth promoter using the active ingredients. Ala, which is the photosensitizer of the present invention, is preferably activated by led radiation, and more preferably activated by radiation having a long wavelength of 650 to 675 nm.
Gwangju Institute Of Science And Technology
05/21/15
20150140138
new patent

Decubitus treatment system


The present invention includes compositions and methods for cleaning, treating, protection and resolution of decubitus ulcers comprising: a first composition comprising a wound cleaning solution comprising aloe vera gel comprising at least 5,000 mps, a balanced salt solution; and a second composition comprising a wound healing gel comprising aloe vera gel comprising at least 10,000 mps, a thickening agent, and one or more preservatives and, optionally, a third composition comprising a moisture barrier cream comprising a vegetable-based emulsifier, a cosmetic ester for dry skin that has low occlusivity, an ester-based emollient that is oxidation stable and has low occlusivity; a beeswax; a hydrogenated oil, glycerin, a buffering agent, aloe vera gel comprising at least 2,000 mps and water.. .
Aloe Bioscience, Llc
05/21/15
20150140132
new patent

Monoterpene glycosyltransferase originating from hop and using same


The present invention provides humulus lupulus-derived monoterpene glycosyltransferase and a method for producing a monoterpene glycoside by means of this enzyme. The present invention provides a transformant transformed with a gene for humulus lupulus-derived monoterpene glycosyltransferase and a method for producing such a transformant..
05/21/15
20150140116
new patent

Bone implant materials comprising cross-linked bioactive hydrogel matrices


The present invention is directed to a stabilized cross-linked hydrogel matrix comprising a first high molecular weight component and a second high molecular weight component that are covalently linked, and at least one stabilizing or enhancing agent, wherein the first high molecular weight component and the second high molecular weight component are each selected from the group consisting of polyglycans and polypeptides. This stabilized hydrogel matrix may be prepared as bioactive gels, pastes, slurries, cell attachment scaffolds for implantable medical devices, and casting or binding materials suitable for the construction of medical devices.
Pioneer Surgical Technology, Inc.
05/21/15
20150140108
new patent

Lipidated glycosaminoglycan particles for the delivery of nucleic acids


There are provided compositions comprising lipidated glycosaminoglycan particles, methods for their preparation and uses thereof for the efficient in-vivo and in-vitro delivery of nucleic acids, such as, sirna molecules.. .
Ramot At Tel-aviv University Ltd.
05/21/15
20150140106
new patent

Ocular nanoformulation and use in angiogenesis-mediated disorders


An ophthalmic formulation that includes nanoparticles. Each nanoparticle includes a shell which encapsulates sulfated non-anticoagulant heparin (snach), with or without hydrophobic anti-angiogenesis tyrosine kinase inhibitors.
05/21/15
20150139920
new patent

Oil-based compositions for enhancing oral health and general wellness in humans


An oil-based composition comprises a glyceride of medium-chain fatty acids, at least one essential oil selected from the group consisting of cinnamon oil, oregano oil, avocado oil, coconut oil and apricot oil, and optionally cinnamon bark. The medium-chain fatty acid comprises about 6 to 12 carbon atoms.
05/21/15
20150136658
new patent

Process for removing ash and heavy hydrocarbons from coal tar


A process for removing ash and heavy hydrocarbon compounds from coal is described. The coal feed, the coal tar stream, or a coal tar fraction is contacted with a solvent to dissolve a soluble portion of the coal tar stream, the ash and heavy hydrocarbons being insoluble in the solvent, the solvent selected from the group consisting of dimethyl sulfoxide, sulfolane, dimethyl formamide, glyme, diglyme, ionic liquids, and combinations thereof, with the proviso that an anion of the ionic liquid is not a dialkylphosphate..
Uop Llc
05/21/15
20150136159
new patent

Filter and tobacco using technology for reducing smell of tobacco smoke on hands


The filter using technology for reducing the smell of tobacco smoke on hands, according to one embodiment of the present invention, comprises: a filter unit for filtering tobacco smoke, the filter unit being coupled to a tobacco shred; and filter-wrapping paper for wrapping the filter unit. The filter unit or the filter-wrapping paper may contain a material for reducing the smell of tobacco smoke.
Kt&g Corporation
05/21/15
20150135587
new patent

Landscaping material with water management properties


A composition is provided as a treatment to be added to landscaping material. The treatment includes glycerin and is applied to the landscaping material at a rate of about 0.3 pounds treatment per cubic yard (178 grams per cubic meter) of landscaping material.
Basf Corporation
05/14/15
20150134115

Commanding a mobile robot using glyphs


A method of operating a robot includes receiving image data from an image capture device of the robot. The image data is representative of a glyph viewed by the image capture device on the display of a computing device within a field of view of the image capture device.
05/14/15
20150133769

Labeled compounds and methods of imaging, diagnosing cartilage disorders and diseases, and monitoring cartilage health using labeled and unlabeled compounds


Novel labeled compounds and metabolites thereof are disclosed, as well as pharmaceutical compositions including the compounds, and methods of using the labeled and unlabeled compounds, and specifically, 2-amino-5-guanidino-pentanoic acid (3-{4-[3-(2-amino-5-guanidino-pentanoylamino)-propyl]-piperazin-1-yl}-propyl)-amide and metabolites thereof, for imaging, detecting and assessing disorders and diseases, such as arthritis and, more specifically, osteoarthritis by tracking proteoglycan and glycosaminoglycan content of cartilage. Also, pharmaceutical compositions comprising labeled and/or unlabeled 1,4-bis(3-aminopropyl)piperazine are disclosed and methods of using the same..
05/14/15
20150133697

Method for producing glycols from oxirane compound


There is provided a method for producing dipropylene glycol (dpg) and/or tripropylene glycol (tpg) including: (a) reacting a raw material liquid including propylene oxide and water to obtain a reaction liquid including unreacted water, propylene glycol (pg), dpg and/or tpg, and an alcohol compound excluding pg, dpg, and tpg; (b) separating, from the reaction liquid, a first liquid containing water and the alcohol compound and a second liquid containing the pg, dpg and/or tpg and optionally the alcohol compound; (c) removing a part of the alcohol compound from the first liquid to obtain a third liquid containing water and optionally a part of the alcohol compound; (d) separating, from the second liquid, a fourth liquid containing the pg and optionally the alcohol compound, and a fifth liquid containing the dpg and/or tpg and optionally the alcohol compound; and (e) recycling a part of the third liquid to step (a).. .
05/14/15
20150133647

Method for producing oligosaccharides and oligosaccharide glycosides by fermentation


The application discloses a method for producing anomerically protected glycosidic oligosaccharide derivatives comprising the step of culturing, in a culture medium containing an anomerically protected lactose acceptor, a genetically modified cell having a recombinant gene that encodes a glycosyl transferase that can transfer a glycosyl residue of an activated sugar nucleotide to said lactose acceptor. The application further discloses a method for producing an oligosaccharide comprising the steps of: (a) culturing, in a culture medium containing an anomerically protected lactose acceptor, a genetically modified cell having a recombinant gene that encodes a glycosyl transferase that can transfer a glycosyl residue of an activated sugar nucleotide to said lactose acceptor to produce an anomerically protected glycosidic oligosaccharide derivative, then (b) removing/deprotecting the anomeric protective group..
05/14/15
20150133639

Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins


Protein glycosylation greatly influences the structure, function, and pharmacokinetics of recombinant proteins. Here, growth media supplemented with metal ions is shown to modulate the protein glycosylation profile of recombinant proteins expressed in a variety of eukaryotic cell lines.
05/14/15
20150133631

Compositions and methods for conjugating oligonucleotides


An oligonucleotide derivative having the structure of formula (a) and methods for preparing the oligonucleotide derivative are disclosed. Wherein r3 is a first oligonucleotide; r1 is selected from the group consisting of alkyl, cycloalkyl, aryl, heterocyclyl, heteroaryl, a polyethylene glycol, a peptide, a protein, a polysaccharide, and a second oligonucleotide; r2 is a linker or a direct bond; z1 is nr4, s, or o, and z2 is nr4 or s, wherein r4 is selected from h, alkyl, aryl, heterocyclyl, or heteroaryl.
05/14/15
20150133567

Composition containing glycerol and glycine


The present invention aims to provide a production method of a composition containing (a) glycerol and (b) glycine, which includes using glycerol substantially free of dihydroxyacetone or having a dihydroxyacetone content of not more than 150 ppm. According to the present invention, a composition, particularly a cosmetic composition, having a moist feeling but free of stickiness and showing suppressed coloration can be provided..
05/14/15
20150133554

Purification of dpa enriched oil


The present invention provides chromatographic means for separating from a starting lipid mixture a mixture that is enriched in docosapentaenoic acid relative to the starting lipid mixture. The invention also provides pharmaceutical formulations and dietary supplements including this enriched lipid formulation, and methods of supplementing docosapentaenoic acid in a subject by administering to the subject the pharmaceutical formulation or the dietary supplement.
05/14/15
20150133508

Use of quaternary pyridinium salts as vasoprotective agents


Wherein r is nh2, ch3, or n(h)ch2oh group, and x is pharmaceutically acceptable counterion, for the preparation of vasoprotective agent for the treatment or prevention of conditions or diseases associated with dysfunction of vascular endothelium, oxidative stress, and/or insufficient production of endothelial prostacyclin pgi2, in particular but not exclusively if the above coincides with hypercholesterolemia, hypertriglyceridemia or low hdl level.. .
05/14/15
20150133497

Glycine reuptake inhibitor and use thereof


Disclosed are a glycine reuptake inhibitor and the use thereof. The glycine reuptake inhibitor is a compound of formula i, or isomers, pharmaceutically acceptable salts or solvates thereof, wherein r1 is one or more groups selected from hydrogen, halogen, c1-6 alkyl, c1-6 alkoxy, nitro, cyano, amino, hydroxyl, c1-6 haloalkyl, and c1-6 haloalkoxy; r2 is selected from hydrogen, c1-6 alkyl, c1-6 alkoxy, c1-6 haloalkyl, and c1-6 haloalkoxy; and each of r3 and r4 is independently selected from hydrogen, halogen, c1-6 alkyl, c1-6 alkoxy, nitro, cyano, amino, hydroxyl, c1-6 haloalkyl, and c1-6 haloalkoxy..
05/14/15
20150133372

Methods and compositions for the induction of hypothermia


Provided herein are methods for the induction of hypothermia and the treatment of clinical insults in a subject through the administration of a regulated hypothermic multidrug combination. The compositions or multidrug combinations of the invention comprise a regulated hypothermic compound or a dopamine receptor agonist; a vasoactive compound; and an antiarrhythmic compound or a serotonin 5-ht3 receptor antagonist.
05/14/15
20150133370

Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging


The present invention relates to dietary compositions comprising reduced level of methionine, tryptophan, all amino acids, or protein, dietary compositions comprising glycerol as a substitute for monosaccharides, disaccharides, and polysaccharides, and hypocaloric or calorie free diets with reduced level of energy, carbohydrates, or protein. Also disclosed are methods of using these compositions and diets, as well as fasting, to protect subjects against chemotherapy, radiotherapy, oxidative stress, or aging..
05/14/15
20150133363

Glut-1 as a receptor for htlv envelopes and its uses


The present application relates to polypeptides derived from the soluble part of the glycoprotein of the enveloped virus of primate t-cell leukemia virus (ptlv), or fragments or variants thereof named receptor binding domain ligands (rbd) selected for their ability to bind specifically to the nutrient transporter glut1.. .
05/14/15
20150132958

Contact release capsule useful for chemical mechanical planarization slurry


The invention relates to a contact release capsule comprising a particle, a chemical payload, and a polymer coating, wherein the particle is impregnated with the chemical payload, and the chemical payload is held inside the particle by the polymer coating until the contact release capsule contacts a surface and a shearing force removes the polymer coating allowing the chemical payload to release outside the particle. The contact release capsule is useful in chemical mechanical planarization slurries.
05/14/15
20150132834

Method for removal of triglycerides in lipoproteins other than low-density lipoproteins


Disclosed is a method for selectively eliminating triglycerides in lipoproteins other than low density lipoprotein, which method allows one to provide a method for directly and differentially quantifying ldl-tg in a sample with excellent simplicity, specificity and accuracy using an automated analyzer or the like without performing a laborious operation of pretreatment such as centrifugation or electrophoresis. The method for eliminating triglycerides in lipoproteins other than low density lipoproteins includes allowing lipoprotein lipase, cholesterol esterase, glycerol kinase and glycerol-3-phosphate oxidase to act on a sample in the presence of a surfactant that acts on lipoproteins other than low density lipoprotein and/or a surfactant having ldl-protecting action, and eliminating hydrogen peroxide produced thereby..
05/14/15
20150132786

Method for measuring glycosylated hemoglobin, measurement reagent, and measurement kit


Described is a method for accurately and highly sensitively measuring glycated hemoglobin in a hemoglobin-containing sample without being influenced by hemoglobin. It is related to a method for measuring glycated hemoglobin in a hemoglobin-containing sample, comprising: reacting hemoglobin-containing sample with a protease in the presence of a surfactant; and then reacting the obtained reaction product with fructosyl peptide oxidase, wherein the latter reaction or both of the former reaction and the latter reaction are performed in the presence of a halogen oxide, and measuring the generated hydrogen peroxide.
05/14/15
20150132784

Methods and kits for detecting a xerophilic microorganism or an osmophilic microorganism


A method for detecting a xerophilic microorganism is provided. The method comprises providing a sample to be tested, an aqueous diluent comprising about 1.0 to about 10.2 weight percent glycerol, and a thin film culture device comprising a cold water-reconstitutable medium to facilitate the growth of a microorganism.
05/14/15
20150132780

Melittin peptide conjugates and methods employing same


Methods and reagents are disclosed for conducting assays for ige specific for honey bee venom allergen. A reagent comprises a conjugate of a small molecule linked to a terminal glycine amino acid of a synthetic 26 amino acid melittin peptide.
05/14/15
20150132466

Nutritional products including a novel fat system including fatty acids


Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component..
05/14/15
20150132434

Spaghetti-like fish products, methods of manufacture thereof


An edible product including surimi, fish or fish portions, in various pasta-like shapes. The edible product has a high satiety index relative to unprocessed cooked fish and also provides a low glycemic index when compared to conventional pasta.
05/14/15
20150132432

Feed composition for reducing ruminant methanogenesis


The present invention refers to a method for reducing methane production in ruminants comprising administering to said ruminant a feed composition containing a flavanone glycoside.. .
05/14/15
20150132409

Agents and devices for affecting nerve function


Agents and devices for affecting nerve function are described. In some variations, a combination of agents, e.g., a cardiac glycoside, an ace inhibitor, and an nsaid are delivered to affect nerve function.
05/14/15
20150132399

Composition and sulfated non-anticoagulant low molecular weight heparins in cancer and tumor metastasis


A nanoformulation that includes nanoparticles. Each nanoparticle includes a shell in which a glycosaminoglycan (gag is encapsulated.
05/14/15
20150132332

Anti-hiv vaccine constructed based on amino acid mutations in attenuated live eiav vaccine


Provided are antigenic polypeptides of hiv envelope glycoproteins which are constructed based on amino acid mutation of attenuated live vaccine of equine infectious anemia virus, dna constructions and recombinant virus vectors comprising polynucleotides encoding said polypeptides, antibodies against said polypeptides as well as uses thereof in preventing and treating hiv infection. Said antigenic polypeptides and vaccines can induce high titer neutralization antibodies against hiv in organism..
05/14/15
20150132320

Mutated anti-tnfa antibodies and methods of their use


The present invention is directed to modified antibodies, including anti-tnfα antibodies, in which c-terminal amino acids of heavy chain sequences are modified from a native sequence of proline-glycine-lysine (“pgk”) to one that includes a proline positioned between the glycine and lysine, resulting in a c-terminal sequence of proline-glycine-proline-lycine (“pgpk”). The invention further provides methods of producing and using such antibodies..
05/14/15
20150132279

Radiation sterilization-resistant protein composition


A protein composition which comprises a mixture of glycine, phenylalanine and histidine and/or a cellulose ether derivative as an additive and has resistance to radiation sterilization.. .
05/14/15
20150132276

Cartilage regeneration-promoting agent


It is an object of the present invention to provide a chondrogenesis promoter that is safe and exhibits a chondrogenesis-promoting effect by daily ingestion. It is also an object of the invention to provide a proteoglycan synthesis promoter that exhibits a proteoglycan synthesis-promoting effect by ingestion.
05/14/15
20150132259

Polyalkylene polymer compounds and uses thereof


The invention relates to novel polyalkylene glycol compounds and methods of using them. In particular, compounds comprising a novel polyethylene glycol conjugate are used alone, or in combination with antiviral agents to treat a viral infection, such as chronic hepatitis c..
05/14/15
20150132241

Antiperspirant active compositions having sec chromatogram exhibiting high sec peak 4 intensity


An aluminum salt composition comprising (a) an aluminum salt having an aluminum to chloride molar ratio of about 0.3:1 to about 3:1, an oh:al molar ratio of about 2:1 to about 2.6:1, exhibiting a size exclusion chromatography (sec) chromatogram having a sec peak 4 to peak 3 intensity ratio of at least 7, and a peak 4 intensity greater than a peak 5 intensity in aqueous solution, and (b) at least one buffer chosen from an amino acid, glycine, and betaine, wherein a molar ratio of buffer to aluminum is about 0.1:1 to about 3:1.. .
05/14/15
20150132228

Compositions and methods to evaluate hepatobiliary/gastrointestinal health, enterohepatic circulation, and drug interactions


The present invention relates to the synthesis and use of a novel trifluorinated bile acid analogue, that being, ca-sar-tfma which is useful as an imaging probe, diagnostic agent or contrast agent and is resistant to bacterial deconjugation, wherein the trifluorinated bile acid analogue can be used as a 19f mri tracer exhibiting an increased half-life due to its resistance to choloylglycine hydrolase.. .
05/14/15
20150132226

Treatment of cancer


This invention relates to the field of molecular physiology. Specifically, this invention relates to the prevention and/or treatment of cancer.


Popular terms: [SEARCH]

Gly topics: Door Assembly, Swimming Goggles, Transverse, Alkoxylate, Fluoropolymer, Air Cleaning, Rotor Shaft, Aspect Ratio, Disconnect, Synchronization, Remote Control, Ethylene Glycol, Surfactant, Combustion, Steviol Glycosides

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Gly for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Gly with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         











0.5424

4508

0 - 1 - 96